News & Events

College Hill Life Sciences winning streak continues

College Hill Life Sciences winning streak continues

15th April 2011, London, Manchester, Munich, Sydney, Boston: The Life Sciences team of international business communications consultancy, College Hill has continued with its winning streak in 2011, securing seven new clients during February and March: these include PR retained clients: Astex Therapeutics, Benitec, e-therapeutics plc, Molecular Partners and Scil Proteins; as well as Aplagon and Cimtech as project clients.

  • Astex Therapeutics is a private UK-based drug discovery company. College Hill was appointed to support Astex's communications activity around its merger with US Listed Biotech Company SuperGen. The team is led by Melanie Toyne-Sewell and Sue Charles.
  • Benitec (ASX:BLT), is an Australian-based ASX-listed company with leading technology in RNA-based gene silencing. College Hill is retained to provide global and local strategic PR and IR counsel, and positioning. The account is led by Sue Charles.
  • e-Therapeutics plc is a UK-based drug discovery and development company, listed on the London Stock Exchange (LSE:ETX). The retained PR/IR account is led by Melanie Toyne-Sewell and was won on the back of College Hill's work to support the announcement of a ¬£21m financing.
  • Molecular Partners is a Swiss-based private biotech company pioneering the development of a novel class of targeted protein therapeutics. This PR account is led by Nicole Yost.
  • Scil Proteins, one of the largest private biotechs in Germany, is a biopharmaceutical company manufacturing and developing proteins and discovering and developing products using its Affilin¬ģprotein scaffold. This PR account is led by Dr Douglas Pretsell.
  • Aplagon is an early stage private biotech company based in Finland. The Company is developing a unique von Willebrand factor (VWF) antagonist with the potential of localised, targeted inhibition of arterial thrombosis. The project team for a new partnering presentation was Sue Charles, Chris Fisher and Dr Eileen Paul.
  • Cimtech is an Australian-based early stage natural products company, developing products based on plants indigenous to the Cook Islands. College Hill was engaged to develop a new identity, website and presentation. The team is Sue Charles, Chris Fisher and Dr. Eileen Paul.

Commenting on the wins Sue Charles, Managing Partner Life Sciences said:"Our unique blend of services that can be tailored to suit the needs of both private and public companies together with our global understanding and reach continues to prove attractive".

These wins follow on the back of four wins at the start of the year - Source BioScience plc, Xellia Pharmaceuticals, 4-Antibody, CellZome and Elastagen.

For further information:

Sue Charles
Managing Partner, Life Sciences
+44 (0)20 7457 2020
+44 (0)7968 726 585

back to news